23 May 2013
Keywords: new, rebif, formulation, launched, uk, switzerland-based, merck
Article | 10 March 2008
Switzerland-based Merck Serono, a division of Germany's Merck KGaA, says that a new formulation of its multiple sclerosis drug Rebif
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 March 2008
© 2013 thepharmaletter.com